Evidence map›Paper›PMID 38716597›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2024

[The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].

S Y Deng, J W Ou, Z C Huang, J J Chen, Z H Cai, Q F Liu, H S Zhou

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

S Y DengDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
J W OuDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Z C HuangDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
J J ChenDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Z H CaiDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Q F LiuDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
H S ZhouDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.

Funding

National Natural Science Foundation of China NFSC82170163、81970147Southern Hospital Clinical Research Fund LC2016ZD009/2019CR012
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene DeletionIkaros Transcription FactorNeoplasm, ResidualHumansPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisRemission InductionRetrospective StudiesSurvival RateIkaros Transcription FactorIKZF1 protein, humanGene, IKZF1Leukemia, B-cell, acuteMinimal residual diseasePediatric-inspired regimen therapy

Identifiers

PMID38716597
PMCPMC11078655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.